RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 4 filers reported holding RECURSION PHARMACEUTICALS IN in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,266 | +202.6% | 557,771 | +195.6% | 0.00% | +200.0% |
| Q2 2023 | $1,410 | +12.4% | 188,668 | +0.2% | 0.00% | 0.0% |
| Q1 2023 | $1,255 | -45.1% | 188,222 | -36.5% | 0.00% | 0.0% |
| Q4 2022 | $2,287 | -99.8% | 296,600 | +164.3% | 0.00% | 0.0% |
| Q3 2022 | $1,195,000 | +619.9% | 112,234 | +448.2% | 0.00% | – |
| Q2 2022 | $166,000 | +0.6% | 20,472 | -11.1% | 0.00% | – |
| Q1 2022 | $165,000 | – | 23,028 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kinnevik AB (publ) | 10,405,668 | $79,603,360 | 100.00% |
| Data Collective IV GP, LLC | 5,941,120 | $45,449,568 | 43.00% |
| MIC Capital Management UK LLP | 8,451,758 | $64,655,952 | 14.74% |
| MV Management XI, L.L.C. | 788,762 | $6,034,029 | 10.04% |
| ArchPoint Investors | 1,047,386 | $8,012,503 | 3.06% |
| Connective Portfolio Management, LLC | 33,000 | $252,000 | 0.77% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,335,132 | $17,863,760 | 0.70% |
| Diametric Capital, LP | 136,331 | $1,042,932 | 0.44% |
| ARK Investment Management | 6,876,598 | $52,605,973 | 0.40% |
| ALLEN OPERATIONS LLC | 217,657 | $1,665,076 | 0.37% |